Long-Term Outcomes Support NCCN Guidelines for Prostate Cancer

Great confirmational news!

A huge study of 62,839 men with nonmetastatic prostate cancer who received primary therapy according to National Comprehensive Cancer Network Clinical Guidelines for Prostate Cancer was just published - July 2025.

Key Takeaways:

Patients with ALL forms of nonmetastatic prostate cancer are more likely to die from other causes than from cancer, when treated per NCCN guidelines.

The 15-year cancer mortality risk is 5.5% for low-risk and 22% for very high-risk patients.

Over 30 years, cancer mortality risk increases to 12% for low-risk and 30% for very high-risk patients.

The risk of dying from other causes is significantly higher, ranging from 63% to 77% over the same period.
https://www.curetoday.com/view/long-term-outcomes-support-nccn-guidelines-for-prostate-cancer